
PF-4708671
CAS No. 1255517-76-0
PF-4708671 ( PF4708671 | PF-4708671 | PF 4708671 )
产品货号. M11039 CAS No. 1255517-76-0
PF-4708671 是一种 p70 核糖体 S6 激酶(S6K1 亚型)的细胞渗透性抑制剂,在无细胞测定中 Ki/IC50 为 20 nM/160 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥381 | 有现货 |
![]() ![]() |
10MG | ¥567 | 有现货 |
![]() ![]() |
25MG | ¥915 | 有现货 |
![]() ![]() |
50MG | ¥1239 | 有现货 |
![]() ![]() |
100MG | ¥2260 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称PF-4708671
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PF-4708671 是一种 p70 核糖体 S6 激酶(S6K1 亚型)的细胞渗透性抑制剂,在无细胞测定中 Ki/IC50 为 20 nM/160 nM。
-
产品描述PF-4708671 is a cell-permeable inhibitor of p70 ribosomal S6 kinase (S6K1 isoform) with Ki/IC50 of 20 nM/160 nM in cell-free assays, 400-fold greater selectivity for S6K1 than S6K2, and 4- and >20-fold selectivity for S6K1 than MSK1 and RSK1/2, respectively. First S6K1-specific inhibitor to be reported.
-
体外实验PF-4708671 inhibits the activity of full-length S6K1 in vitro with a Ki of 20 nM, and S6K1 isolated from IGF1-stimulated HEK293 cells with an IC50 of 0.16 μM, and only inhibits very weakly the closely related S6K2 isoform (IC50 of 65 μM). PF-4708671 inhibits RSK1 (IC50 of 4.7 μM) and RSK2 (IC50 of 9.2 μM) over 20-fold less potently than S6K1. PF4708671 inhibits MSK1 (IC50 of 0.95 μM) 4-fold more weakly than S6K1. HCT116 cells are treated with (i) vehicle (DMSO), (ii) OSI-906 (5 μM), (iii) PF-4708671 (10 μM), and (iv) OSI-906 (5 μM)+PF-4708671 (10 μM) for various amounts of time. HCT116 cells treated with OSI-906 alone (closed square) or PF4708671 alone (open circle) slightly inhibit cell growth. In contrast, proliferation in HCT116 cells is significantly inhibited after a 2-day treatment with the combination of OSI-906 and PF-4708671 (closed circle). A similar result is also observed when SW480 cells are treated with the combination of OSI-906 and PF-4708671. Colony formation also significantly reduces in OSI-906+PF-4708671-treated cells comparing with vehicle, OSI-906 alone, or PF-4708671 alone treated HCT116 or SW480 cells.
-
体内实验The tumor growth rate in mice treated with the combination of OSI-906+PF-4708671 is significantly slower than that of OSI-906 alone (P=0.0189) or PF4708671 alone (P=0.0165) treated mice. The average tumor volume in the OSI-906+PF-4708671-treated mice is approximately 50% of that in mice treated with OSI-906 (P=0.0056) or PF-4708671 alone (P<0.001) at the end of a 15-day treatment.
-
同义词PF4708671 | PF-4708671 | PF 4708671
-
通路PI3K/Akt/mTOR signaling
-
靶点S6 Kinase
-
受体p70 S6K
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1255517-76-0
-
分子量390.41
-
分子式C19H21F3N6
-
纯度>98% (HPLC)
-
溶解度Ethanol: 8 mg/mL (20.49 mM); DMSO: 30 mg/mL (76.84 mM)
-
SMILESFC(C1=CC=C2NC(CN3CCN(C4=NC=NC=C4CC)CC3)=NC2=C1)(F)F
-
化学全称2-((4-(5-ethylpyrimidin-4-yl)piperazin-1-yl)methyl)-5-(trifluoromethyl)-1H-benzo[d]imidazole
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Pearce LR, et al. Biochem J, 2010, 431(2), 245-255.